February 28, 2022
Nigel Key, MB, ChB, FRCP has been awarded a 5-year, $2.2 million T32 grant from the National Heart, Lung, and Blood Institute (NHLBI). Now closely aligned with the benign hematology research areas of focus in the Blood Research Center (hemostasis, thrombosis and sickle cell disease), the program will continue to recruit MD and PhD trainees for …
February 21, 2022
UNC Blood Research Center member Stephan Moll, MD is a coauthor on a paper published in the Journal of Thrombosis and Haemostasis. The article, Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis” provides data showing that women with DVT or PE associated with estrogen-containing contraceptives, the risk …
February 17, 2022
Steven Grover, PhD, a postdoctoral fellow in the laboratory of Nigel Mackman, has been selected to receive a Fellow to Faculty Scholar Award from the American Society of Hematology. The prestigious ASH Scholar Awards provide financial support to fellows and junior faculty with dedicated careers in hematology research, as they transition from training programs to …
February 16, 2022
UNC BRC Faculty members Dr. Erica Sparkenbaugh, Dr. Rafal Pawlinski, and Dr. Nigel Key are highlighted in a Photo Essay called “Magnificent Magnification” in the UNC Research newsletter, Endeavors. The image is a scanning electron micrograph of a blood clot from a patient with sickle cell disease. https://endeavors.unc.edu/magnificent-magnification/
December 12, 2019
My groups research is focused on identifying novel mechanisms responsible for pathological activation of coagulation and venous thromboembolism. Venous thromboembolism, including deep vein thrombosis and pulmonary embolism, is a common cardiovascular disease that is a major source of morbidity and mortality worldwide.
December 9, 2019
My research is focused on studying the influence of biochemical and biophysical mechanisms on blood coagulation, clot formation, and bleeding. My methodology involves the integration of mathematical, statistical, and experimental approaches to determine mechanisms underlying complex biological phenomena.
December 5, 2019
As a part of the Bergmeier research group my efforts are focused on understanding the intricacies of platelet signaling, primarily as it relates to thrombosis and hemostasis.
December 4, 2019
I am an enthusiastic and solid medical scientist, passionate about RNA and hematopoietic stem cells (HSC), an extremely relevant research area of interest of the BRC. Eventually, I aim to improve our transfusion and bone marrow transplant practices based in novel discoveries. Our lab is committed to embrace individuals from all backgrounds and groups, including, but not restricted to those from historically excluded minorities. The diversity of our team creates an inclusive, collegial, supportive-equitable team, sustained by our different backgrounds united towards scientific understanding. We consider the education process as being dynamic and transformative. In ways that that the unforeseen novel knowledge leads a to an empowered society. These are also goals shared by the BRC mission at UNC.